CHENG TAI – Trademark Portfolio
Entity Type: 01
CHENG TAI holds 33 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 25 (Clothing) — 27 filings in this category. The portfolio also extends into Class 14 (Jewelry) across 7 Nice Classification classes. Currently, 18 trademarks are registered. Notable registered marks include OCIA, EBLIN, IAIZO, PRICH, and NAERSI. The owner is based in ZHEJIANG SHENG.
YUAN,JIANG DONG JIE DAO, YIWU SHI
2303 SHI, C QU 6 ZHUANG,SHANG BO HUA
ZHEJIANG SHENG 322000 , CN
Showing of trademarks Trademarks
Trademark Classifications
CHENG TAI's trademark portfolio spans 7 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Precious metals and their alloys; jewellery, precious stones; horological instruments
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Lace and embroidery, ribbons and braid; buttons, hooks and eyes, pins and needles
Carpets, rugs, mats and matting, linoleum and other materials for covering floors
Frequently Asked Questions
How many trademarks does CHENG TAI have?
CHENG TAI has 33 U.S. trademarks filed with the USPTO. Of these, 18 registered, 9 abandoned, 6 cancelled.
What trademark classes does CHENG TAI file in?
CHENG TAI files trademarks across 7 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 14 (Jewelry), Class 10 (Medical Apparatus), Class 44 (Medical Services), Class 21 (Housewares). Class 25 covers clothing, footwear, headgear.
What are CHENG TAI's most well-known trademarks?
CHENG TAI's registered trademark portfolio includes well-known marks such as OCIA, EBLIN, IAIZO, PRICH, and NAERSI. These are among 18 currently registered trademarks in the portfolio.
What is CHENG TAI's trademark registration success rate?
CHENG TAI has a 55% trademark registration rate, with 18 out of 33 resolved applications resulting in successful registration. Currently, 0 applications are pending review.